Table 2.
Comparison of different variables between M1E0S0T0 and M1E0S1T0 IgAN patients
| Variables | Group 2A (n = 21) | Group 2 B (n = 18) | p value |
|---|---|---|---|
| Age, years | 45 (17–69) | 33.5 (18–77) | 0.0569 |
| Males, n | 10 (48) | 9 (50) | ns |
| Hypertensives, n | 2 (10) | 4 (23) | ns |
| Follow-up, years | 7.2 (6.7–7.8) | 7.5 (6.9–8.1) | ns |
| CKD-EPI, mL/min | 104 (47–154) | 67.5 (23–161) | 0.0027 |
| Proteinuria/creatinuria, g/g | 0.16 (0.01–1.11) | 0.92 (0.04–14.81) | 0.034 |
| uCD80, ng/gUrCr | 45.84 (0–526.10) | 110.68 (0–361.86) | 0.0586 |
| uPAR podocytes/creatinuria, cells/g | 17.75 (1.97–192.31) | 36.42 (8.19–17345) | 0.0242 |
Values in parentheses represent range or percentage. IgAN, IgA nephropathy; CKD-EPI, Chronic Kidney Disease-Epidemiology Collaboration; uCD80, urinary CD80; gUrCr, gram of urinary creatinine; uPAR, urokinase-type plasminogen activator receptor; ns, nonsignificant.